GB201905631D0 - Bicyclic peptide ligands specific for pd-l1 - Google Patents
Bicyclic peptide ligands specific for pd-l1Info
- Publication number
- GB201905631D0 GB201905631D0 GBGB1905631.6A GB201905631A GB201905631D0 GB 201905631 D0 GB201905631 D0 GB 201905631D0 GB 201905631 A GB201905631 A GB 201905631A GB 201905631 D0 GB201905631 D0 GB 201905631D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- peptide ligands
- ligands specific
- bicyclic peptide
- bicyclic
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1905631.6A GB201905631D0 (en) | 2019-04-23 | 2019-04-23 | Bicyclic peptide ligands specific for pd-l1 |
JP2021535745A JP2022514618A (en) | 2018-12-21 | 2019-12-23 | Bicyclic peptide ligand specific for PD-L1 |
EP19831858.6A EP3897849A1 (en) | 2018-12-21 | 2019-12-23 | Bicyclic peptide ligands specific for pd-l1 |
CN201980081015.6A CN113474045A (en) | 2018-12-21 | 2019-12-23 | PD-L1 specific bicyclic peptide ligands |
US17/044,868 US20220306689A9 (en) | 2018-12-21 | 2019-12-23 | Bicyclic peptide ligands specific for pd-l1 |
PCT/GB2019/053679 WO2020128526A1 (en) | 2018-12-21 | 2019-12-23 | Bicyclic peptide ligands specific for pd-l1 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1905631.6A GB201905631D0 (en) | 2019-04-23 | 2019-04-23 | Bicyclic peptide ligands specific for pd-l1 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201905631D0 true GB201905631D0 (en) | 2019-06-05 |
Family
ID=66810174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1905631.6A Ceased GB201905631D0 (en) | 2018-12-21 | 2019-04-23 | Bicyclic peptide ligands specific for pd-l1 |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201905631D0 (en) |
-
2019
- 2019-04-23 GB GBGB1905631.6A patent/GB201905631D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202100442B (en) | Bicyclic peptide ligands specific for nectin-4 | |
IL283873A (en) | Bicyclic peptide ligands specific for mt1-mmp | |
IL287881A (en) | Bicyclic peptide ligands specific for ox40 | |
IL283874A (en) | Bicyclic peptide ligands specific for mt1-mmp | |
GB201900526D0 (en) | Bicyclic peptide ligands specific for caix | |
GB201820295D0 (en) | Bicyclic peptide ligands specific for MT1-MMP | |
GB201820320D0 (en) | Bicyclic peptide ligands specific for FAPalpha | |
GB201900525D0 (en) | Bicyclic peptide ligands specific for caix | |
GB201900530D0 (en) | Bicyclic peptide ligands specific for CD38 | |
GB201905631D0 (en) | Bicyclic peptide ligands specific for pd-l1 | |
GB201904622D0 (en) | Bicyclic peptide ligands specific for pd-l1 | |
GB201904621D0 (en) | Bicyclic peptide ligands specific for PD-L1 | |
GB201820956D0 (en) | Bicyclic peptide ligands specific for pd-l1 | |
GB201918495D0 (en) | Bicyclic peptide ligands specific for il-46 | |
GB201904632D0 (en) | Bicyclic peptide ligands specific for nectin-4 | |
GB201818499D0 (en) | Bicyclic peptide ligands specific for nectin-4 | |
GB201815684D0 (en) | Bicyclic peptide ligands specific for nectin-4 | |
GB201712571D0 (en) | Bicyclic peptide ligands specific for PD-L1 | |
GB201820969D0 (en) | Bicyclic peptide ligands specific for pd-l | |
GB201918497D0 (en) | Bicyclic peptide ligands specific for klk7 | |
GB201918488D0 (en) | Bicyclic peptide ligands specific for chymase | |
GB201918496D0 (en) | Bicyclic peptide ligands specific for klk5 | |
GB201805850D0 (en) | Bicyclic peptide ligands specific for cd137 | |
GB201918489D0 (en) | Bicyclic peptide ligands specific for hsp90 | |
GB201802934D0 (en) | Bicyclic peptide ligands specific for CD137 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |